Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha(1)-Blockade in the nineties: focus on the patient.

M P O'Leary1

  • 1Department of Surgery, Harvard Medical School, Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.

Prostate Cancer and Prostatic Diseases
|December 24, 2002
PubMed
Summary

Benign prostatic hyperplasia (BPH) causes lower urinary tract symptoms (LUTS) that negatively impact quality of life and sexual function. Alpha-blockers, like alfuzosin, may improve these symptoms and sexual health in aging men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fractured penis: a review.

International journal of impotence research·2008
Same author

Dutasteride significantly improves quality of life measures in patients with enlarged prostate.

Prostate cancer and prostatic diseases·2007
Same author

Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2006
Same author

Distribution of the Brief Male Sexual Inventory in community men.

International journal of impotence research·2003
Same author

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.

BJU international·2003
Same author

Early ejaculation.

BJU international·2003

Area of Science:

  • Urology
  • Andrology
  • Geriatrics

Background:

  • Lower urinary tract symptoms (LUTS) affect a significant percentage of aging men, with prevalence increasing with age.
  • These symptoms, often associated with benign prostatic hyperplasia (BPH), negatively impact patients' quality of life (QoL) and sexual function.
  • Existing questionnaires can assess LUTS severity, QoL, and sexual function.

Purpose of the Study:

  • To review the impact of LUTS/BPH on QoL and sexual function.
  • To discuss the role of alpha(1)-blockers, specifically alfuzosin, in managing LUTS/BPH.
  • To explore the potential direct or indirect effects of alfuzosin on sexual function.

Main Methods:

  • Literature review of studies assessing LUTS, BPH, QoL, and sexual function.

Related Experiment Videos

  • Analysis of comparative studies on symptom severity and its impact.
  • Examination of treatment outcomes with alpha(1)-blockers.

    • Main Results:

    • Increasing LUTS severity correlates with decreased QoL, general health status, and sexual function.
    • Treatment of LUTS generally improves patient QoL.
    • Alpha(1)-blocker alfuzosin has demonstrated potential to improve sexual drive and function, though the mechanism is unclear.

    Conclusions:

    • Physicians must consider the QoL aspects of BPH, including sexual function, in aging males.
    • Alpha(1)-blockers are effective for LUTS/BPH and may offer additional benefits for sexual health.
    • Further research is needed to elucidate the direct mechanisms by which alfuzosin influences sexual function.